Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy.
Oncoimmunology
; 5(7): e1151595, 2016 Jul.
Article
in En
| MEDLINE
| ID: mdl-27622016
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Oncoimmunology
Year:
2016
Document type:
Article
Affiliation country:
Estados Unidos